OrganiGram (OGI)
(Delayed Data from NSDQ)
$1.47 USD
-0.07 (-4.55%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $1.46 -0.01 (-0.68%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Brokerage Reports
Organigram Holdings Inc. [OGI]
Reports for Purchase
Showing records 1 - 20 ( 31 total )
Company: Organigram Holdings Inc.
Industry: Medical - Products
Company: Organigram Holdings Inc.
Industry: Medical - Products
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Toronto Securities Exchange an Open Pathway for MSO Lisitngs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Israel - Pioneering Cannabis into a Large Market Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis SPACs Underperformed in 2021, Reset
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: CAOA Feedback, Fall Potential Legislation Passage In Budget Bill
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
Weekly ReHash: Ranking 2Q Earnings Reports, Well Capitalized MSOs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Organigram Holdings Inc.
Industry: Medical - Products
A Day of Progress for Cannabis Legislative Reform
Provider: Roth Capital Partners, Inc.
Analyst: Research Department